Lucence is a precision oncology company founded on a vision of a world without avoidable cancer deaths. We develop advanced liquid biopsy blood tests that select suitable cancer treatments through molecular profiling. Headquartered in Singapore and San Francisco, with offices in Hong Kong and Suzhou, our clinical services are delivered worldwide through a U.S. CLIA-licensed, CAP and ISO15189-accredited laboratory.
For speaking, sponsorship and exhibition opportunities contact
jonathan.mottram@terrapinn.com
Tel: +65 6322 2738